Table 1.
LA group (n=22) | LAD group (n=23) | P | |
---|---|---|---|
Age (years)* | 5.0 (8-3.25) | 7.0 (8-4.5) | 0.330 |
Weight (kg)† | 19.2±5.8 | 22.1±6.1 | 0.112 |
Gender (M: F) number (%)‡ | 16:6 (73:27) | 13:10 (56:44) | 0.256 |
Duration of anaesthesia (min)† | 167.8±60.4 | 169.4±54.7 | 0.925 |
Duration of surgery (min)† | 130.7±57.5 | 128.8±52.3 | 0.906 |
Laparoscopic surgical procedures‡ | |||
Appendicectomy | 2 (40) | 3 (60) | 0.817 |
Cholecystectomy | 5 (42) | 7 (58) | |
Choledochal cyst removal | 5 (45) | 6 (55) | |
Nephrectomy | 6 (75) | 2 (25) | |
Pyeloplasty | 1 (50) | 1 (50) | |
Splenectomy | 1 (33) | 2 (67) | |
Others | 2 (50) | 2 (50) |
*Values expressed as median (IQR) and analysed using Mann-Whitney U test; †Values expressed as mean±SD and analysed using unpaired t test; ‡Values expressed as number (%) and analysed using Chi-square test. Group LA: Total 0.5 ml/kg of 0.2% ropivacaine, Group LAD: Total 0.5 ml/kg of 0.2% ropivacaine with 1 μg/kg dexmedetomidine